VL Study Groups

IDDO facilitates collaborative Study Groups to undertake individual patient data meta-analyses to answer specific research questions about visceral leishmaniasis (VL) treatments. Gathering and combining datasets from multiple studies allows for the study of differential treatment effects across sub-populations of interest and helps to explore sources of between-study heterogeneity in therapeutic responses.

Working together, and combining data from different regions and populations, is improving our understanding of the disease, and will advance research and subsequent drug development.

Doctors in clinic
Credit Aisha Faquir, World Bank